BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31506224)

  • 41. Expression analysis and biological characterization of Babesia sp. BQ1 (Lintan) (Babesia motasi-like) rhoptry-associated protein 1 and its potential use in serodiagnosis via ELISA.
    Niu Q; Liu Z; Yang J; Yu P; Pan Y; Zhai B; Luo J; Moreau E; Guan G; Yin H
    Parasit Vectors; 2016 May; 9(1):313. PubMed ID: 27245213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of profilin antigen among Babesia species as a common vaccine candidate against babesiosis.
    Munkhjargal T; Aboge GO; Ueno A; Aboulaila M; Yokoyama N; Igarashi I
    Exp Parasitol; 2016 Jul; 166():29-36. PubMed ID: 27003460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens.
    Fish L; Leibovich B; Krigel Y; McElwain T; Shkap V
    Vaccine; 2008 Dec; 26 Suppl 6():G29-33. PubMed ID: 19178890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoprophylactic control of bovine babesiosis: role of exoantigens of Babesia.
    Montenegro-James S
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():85-94. PubMed ID: 2696166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of a Babesia orientalis apical membrane antigen, and comparison of its orthologues among selected apicomplexans.
    He L; Fan L; Hu J; Miao X; Huang Y; Zhou Y; Hu M; Zhao J
    Ticks Tick Borne Dis; 2015 Apr; 6(3):290-6. PubMed ID: 25732411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Live and soluble antigens for cattle protection to Babesia bigemina.
    Echaide IE; de Echaide ST; Guglielmone AA
    Vet Parasitol; 1993 Dec; 51(1-2):35-40. PubMed ID: 8128585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient transfection of Babesia ovis using heterologous promoters.
    Rosa C; Asada M; Hakimi H; Domingos A; Pimentel M; Antunes S
    Ticks Tick Borne Dis; 2019 Oct; 10(6):101279. PubMed ID: 31481343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Invasiveness and immunogenicity of Babesia ovis in sheep].
    Khalacheva M
    Vet Med Nauki; 1979; 16(4):78-83. PubMed ID: 532095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole genome sequence and diversity in multigene families of
    Yamagishi J; Ceylan O; Xuan X; Sevinc F
    Front Cell Infect Microbiol; 2023; 13():1194608. PubMed ID: 37662008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
    Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
    Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of antibodies to Babesia equi in horses by a latex agglutination test using recombinant EMA-1.
    Xuan X; Igarashi I; Tanaka T; Fukumoto S; Nagasawa H; Fujisaki K; Mikami T
    Clin Diagn Lab Immunol; 2001 May; 8(3):645-6. PubMed ID: 11329474
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Sevinc F; Zhou M; Cao S; Ceylan O; Ulucesme MC; Ozubek S; Aktas M; Xuan X
    Front Cell Infect Microbiol; 2023; 13():1238369. PubMed ID: 37662014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a polymerase chain reaction method for diagnosis of Babesia ovis infection in sheep and goats.
    Aktaş M; Altay K; Dumanli N
    Vet Parasitol; 2005 Nov; 133(4):277-81. PubMed ID: 16043298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Babesia gibsoni ribosomal phosphoprotein P0 induces cross-protective immunity against B. microti infection in mice.
    Terkawi MA; Jia H; Zhou J; Lee EG; Igarashi I; Fujisaki K; Nishikawa Y; Xuan X
    Vaccine; 2007 Mar; 25(11):2027-35. PubMed ID: 17229504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of antioxidant status and oxidative stress in sheep naturally infected with Babesia ovis.
    Esmaeilnejad B; Tavassoli M; Asri-Rezaei S; Dalir-Naghadeh B
    Vet Parasitol; 2012 Apr; 185(2-4):124-30. PubMed ID: 22030375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospects for recombinant vaccines against Babesia bovis and related parasites.
    Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
    Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
    Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunization of Bos taurus steers with Babesia bovis recombinant antigens MSA-1, MSA-2c and 12D3.
    Antonio Alvarez J; Lopez U; Rojas C; Borgonio VM; Sanchez V; Castañeda R; Vargas P; Figueroa JV
    Transbound Emerg Dis; 2010 Apr; 57(1-2):87-90. PubMed ID: 20537116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
    Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
    Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.